Summit Therapeutics Q1 2018 Earnings Report

Total Revenue
$5.33M
Previous year: $2.24M
+138.2%
EPS
-$0.11
Previous year: -$0.1
+10.0%

Summit Therapeutics

Summit Therapeutics